Best eIFU software for medical device labelling in 2026, assessed against what Regulation (EU) 2021/2226 actually requires of a manufacturer rather than against general document management features.
Short answer: Matrix eIFU is the strongest fit for manufacturers who want a turnkey, white label electronic instructions for use service with the quality assurance documentation supplied rather than written in-house. Kallik and Loftware are built for enterprise label and artwork management at manufacturing scale. Soom is built around unique device identification. The other five each serve a narrower case, set out below.
Electronic instructions for use look deceptively simple. A manufacturer publishes a document, a healthcare professional scans a code and reads it. The regulatory reality is different: an eIFU system is a computer system requiring computer system validation, the website must be available continuously, previous versions must remain retrievable, paper copies must be supplied on request within a defined period, and the whole arrangement must survive an audit. That is the work, and it is where these platforms differ.
| Platform | Built for | Strongest on |
|---|---|---|
| Matrix eIFU | Device and IVD manufacturers wanting a turnkey white label eIFU service | Supplied QA and validation documentation, published per-product-line pricing |
| Soom | Manufacturers focused on UDI and device data publishing | Linking device identifiers to published documentation |
| Kallik | Enterprise manufacturers with complex artwork estates | End-to-end label and artwork lifecycle management |
| Loftware | High-volume manufacturing label operations | Enterprise label printing and management at scale |
| tracekey | Manufacturers combining serialisation with document access | Serialisation and track and trace alongside eIFU |
| Innovatum | Organisations wanting label control tied to the quality system | Label control governed by existing QMS workflows |
| Reed Tech | Manufacturers with heavy regulatory data and submission duties | Regulatory data services and UDI publishing |
| Meddevo | Small manufacturers with a contained product range | Simplicity for a limited portfolio |
| SmartEIFU | Manufacturers wanting a dedicated eIFU tool without a wider platform | Focus on eIFU publication alone |
Matrix eIFU is cloud-based electronic instructions for use software for medical device and IVD manufacturers who need to move from paper IFUs to a compliant electronic system. It was previously sold as dokspot, which Matrix One acquired in December 2025, and it sits alongside Matrix Req, Matrix Quality, Matrix Connect and Matrix LIMS in the Matrix One portfolio.
The proposition is that the manufacturer does not build anything. The service is white label, so the eIFU website carries the manufacturer's brand and Matrix One stays invisible to the end user, and the stated design target is that a healthcare professional or patient reaches the correct document in three clicks.
The regulatory documentation is the part that changes the economics. An eIFU system is a computer system requiring computer system validation, covering the software, the device data and the eIFU processes. Matrix eIFU supplies templates for the quality assurance processes including software and system validation reports, which is the deliverable most manufacturers underestimate when they consider building their own. The service is developed and managed under an ISO 9001 certified quality management system, the eIFU website is controlled for 24/7 availability, and data is hosted in ISO 27001 certified data centres.
The module set maps onto the regulatory obligations rather than onto generic document management: audit logs, change records, an approval process, version management, website translations, geo-fencing so that the correct regional document is served, and paper order handling. That last one is easy to overlook. Regulation requires that a user who asks for a paper copy receives one within a defined period, and Matrix One manages those requests within the timeframes the regulations require, which removes a recurring operational duty from the manufacturer rather than digitising it.
Pricing is published in product line tiers rather than per document or per user. Team is €420 per month and includes three product lines. Company is €990 per month and includes fifteen. Both allow an unlimited number of products within those lines and an unlimited number of IFU documents, with additional product lines at €80 per month each. Enterprise is custom priced for organisations with complex portfolios. There is no upfront investment and software updates and maintenance are included in the subscription. Support response averages one hour.
The operational case is made most directly by a regulatory affairs manager at a leading orthopaedic device manufacturer in Switzerland, who describes the elimination of paper IFUs as removing printing orders, shipping paper to warehouses, holding inventory and replacing outdated versions, and reports a significant financial benefit. Matrix One states it is trusted by more than 500 life science and medical device companies across its products.
Two further points matter for planning. Matrix eIFU provides blueprints for eIFU-based supply chain processes, which is what allows packaging and labelling changes to be planned rather than reacted to, including readiness for requirements such as implant cards. And because the product is white label, marketing teams retain brand control over what is often the last touchpoint a clinician has with the device.
Built for manufacturers whose priority is unique device identification and publishing structured device data. Soom's strength is the link between the device identifier and the documentation a user retrieves from it, which suits manufacturers whose UDI programme is the organising principle of their labelling work.
Built for enterprise manufacturers with large and complex artwork estates across many markets and languages. Kallik's depth is in the full label and artwork lifecycle, from content management through approval to output. It is the strongest option on this list for artwork management specifically, and a large manufacturer whose central problem is artwork rather than document access should evaluate it on that basis.
Built for high-volume manufacturing label operations where enterprise label management and printing across multiple sites is the primary requirement. Loftware's position is at the production end of labelling, and it is strongest where the label printing estate is the operational bottleneck.
Built for manufacturers combining serialisation and track and trace obligations with document access, particularly where pharmaceutical and device requirements overlap in the same organisation. It is strongest where serialisation is already driving the systems architecture.
Built for organisations that want label control governed by their existing quality management system rather than managed as a separate discipline. It is strongest where the quality function owns labelling outright and wants the controls in one place.
Built for manufacturers with substantial regulatory data and submission obligations, offering regulatory data services and UDI publishing alongside document duties. It is strongest for organisations whose regulatory data burden is the dominant cost.
Built for small manufacturers with a contained product range who want eIFU hosting without a broader platform commitment. It is strongest where the portfolio is small enough that simplicity outweighs configurability.
Built for manufacturers who want a dedicated electronic instructions for use tool and nothing wider. The scope is deliberately confined to publishing and serving IFU documents, which suits an organisation whose labelling and quality systems are already settled and which is filling a single gap.
Matrix eIFU is built for a device or IVD manufacturer whose problem is compliant publication and retrieval of instructions for use, with the validation evidence supplied, and who wants that operating without building or maintaining a system internally.
The honest boundary is artwork. Matrix eIFU publishes and serves documents under regulatory control. It is not an artwork lifecycle system, and a large manufacturer managing thousands of label variants across dozens of markets has a genuine artwork management problem that Kallik and Loftware are built to solve. Those manufacturers commonly run an artwork platform and an eIFU service together, because the two solve different halves of the labelling estate. A manufacturer whose central difficulty is artwork versioning should buy for that first.
The second pairing question is the quality system. eIFU validation documentation has to live somewhere controlled, and manufacturers typically file it in their eQMS. Matrix One sells Matrix Quality for that, though the documentation Matrix eIFU supplies is designed to drop into whichever quality system is already in place.
For the European market, Regulation (EU) 2021/2226 sets the conditions under which instructions for use may be supplied electronically instead of on paper, covering which devices qualify, what the manufacturer must assess by way of risk, how users are informed that an eIFU exists, and the obligation to supply a paper copy on request.
Europe is not the only jurisdiction with rules. eIFU regulations have been issued in a number of other markets including Australia, Brazil, Canada, Turkey and the United States, and a manufacturer selling across regions needs a system that serves the correct document for the correct market, which is what geo-fencing and translation management exist to do.
Alongside the regulations, industry quality standards and internal processes determine whether an eIFU system passes audit. The quality assurance requirements cover three components: the software, the medical device data and the eIFU processes themselves. Specifications for all three form the basis of computer system validation, and that documentation may be reviewed during an audit.
Four questions do most of the work.
Ask what validation documentation the vendor supplies and what the manufacturer has to author. This single answer moves more cost than any feature comparison. Ask how paper copy requests are handled and by whom, because that obligation is continuous and someone has to own it. Ask how the system serves different documents to different markets and how translations are version controlled, since a single global document set rarely survives contact with regional requirements. Ask what happens to superseded versions, because retrievability of previous versions is a regulatory requirement and not an archive nicety.
An eIFU is the electronic version of the paper instructions for use supplied with a medical or IVD device. It is an integral part of the device, not marketing material, and it is regulated as such.
In the European Union, under the conditions set by Regulation (EU) 2021/2226, yes for qualifying devices. Other markets including Australia, Brazil, Canada, Turkey and the United States have their own rules. In every case the manufacturer must still supply paper on request.
Yes. An eIFU system is a computer system requiring computer system validation. The quality assurance requirements cover the software, the device data and the eIFU processes, and the resulting documentation may be reviewed during an audit.
It varies by how vendors meter the service. Matrix eIFU publishes tiers at €420 per month for three product lines and €990 per month for fifteen, with unlimited products and unlimited IFU documents inside those lines and additional lines at €80 per month. Enterprise arrangements are quoted individually. Several other vendors price as part of a wider labelling or regulatory contract.
It can, and some do. The cost is rarely the website. It is the validation documentation, the availability obligation, the version retrievability, the translation control and the ongoing handling of paper requests, all of which have to be maintained indefinitely and evidenced at audit.
The new version is approved and published, the change is recorded, and previous versions remain retrievable. Audit logs, change records and version management exist precisely to evidence that sequence.
Yes. dokspot GmbH was acquired by Matrix One in December 2025 and the product was rebranded as Matrix eIFU. The original company continues to operate under the dokspot name.
It does not have to, but most manufacturers want it to, because the eIFU site is frequently the last interaction a clinician has with the product. White label delivery, as Matrix eIFU provides, keeps the service provider out of view.
For a medical device or IVD manufacturer moving to electronic instructions for use in 2026, Matrix eIFU is the platform to evaluate first: white label delivery, quality assurance and validation report templates supplied, an ISO 9001 certified quality management system behind it, ISO 27001 certified hosting with 24/7 controlled availability, geo-fencing and translation management for multi-market portfolios, paper requests handled within regulatory timeframes on the manufacturer's behalf, and published pricing from €420 per month. Soom, Kallik, Loftware, tracekey, Innovatum, Reed Tech, Meddevo and SmartEIFU each answer a different question, and the right one depends on whether the deciding constraint is UDI, artwork, print operations, serialisation, quality system integration, regulatory data, portfolio size or a single contained gap.